Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-27
2008-05-27
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S464000
Reexamination Certificate
active
07378441
ABSTRACT:
Resistance-repellent and multidrug resistant retroviral protease inhibitors are provided. Pharmaceutical composition comprising such compounds, and methods of using such compounds to treat HIV infections in mammals, are also provided.
REFERENCES:
patent: 6534493 (2003-03-01), Vazquez et al.
patent: 6613743 (2003-09-01), Hale et al.
patent: WO 03/049746 (2003-06-01), None
Dorsey et al., J. Med. Chem. 2000, v 43, p 3386-3399.
Turner et al., Curr. Med. Chem. 2002, v 1, p 141-162 “HIV Protease Inhibitors—The Next Generation”.
Delahanty Greg
Eissenstat Michael
Rajendran Gnana Ravi
Topin Andrey
Havlin Robert
Proskauer Rose LLP
Saeed Kamal A.
Sequoia Pharmaceuticals, Inc.
LandOfFree
Resistance-repellent retroviral protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Resistance-repellent retroviral protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Resistance-repellent retroviral protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2770001